Zobrazeno 1 - 10
of 65
pro vyhledávání: '"ZA Hughes"'
Publikováno v:
British Journal of Pharmacology. 127:1860-1866
1. The effects of sibutramine (0.25 - 10 mg kg-1, i.p.) on extracellular noradrenaline concentration in the frontal cortex of halothane-anaesthetized rats were compared with those of d-amphetamine (1 - 3 mg kg-1, i.p.) using in vivo microdialysis. Th
Autor:
S. Clare Stanford, ZA Hughes
Publikováno v:
British Journal of Pharmacology. 124:1141-1148
1 Microdialysis of the frontal cortex of freely-moving rats and uptake of [3H]noradrenaline into cortical synaptosomes were used to evaluate changes in efflux of noradrenaline in vivo and uptake of [3H]noradrenaline in vitro, respectively, induced by
Autor:
ZA Hughes, SC Stanford
Publikováno v:
Psychopharmacology. 136(3)
The effect of systemic administration of the selective neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on noradrenaline efflux in the frontal cortex was studied in freely-moving rats using microdialysis in vivo. Five days after treatm
Autor:
Christopher Wilkinson, Za, Hughes-Thomas, Cj, Martin, Böhm I, Mironenko T, Deacon M, Wheatcroft M, Wirtz G, Staunton J, Pf, Leadlay
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::46c0c2c40f43b6f59b1e1f49d78949dc
http://www.scopus.com/inward/record.url?eid=2-s2.0-0035988290&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0035988290&partnerID=MN8TOARS
Autor:
Klein AK; Gilgamesh Pharmaceuticals, New York, NY, USA. adam@gilgameshpharmaceutical.com., Austin EW; Gilgamesh Pharmaceuticals, New York, NY, USA., Cunningham MJ; Gilgamesh Pharmaceuticals, New York, NY, USA., Dvorak D; Gilgamesh Pharmaceuticals, New York, NY, USA., Gatti S; McArthur and Associates, Basel, Switzerland., Hulls SK; Gilgamesh Pharmaceuticals, New York, NY, USA., Kiss L; Gilgamesh Pharmaceuticals, New York, NY, USA., Kruegel AC; Gilgamesh Pharmaceuticals, New York, NY, USA., Marek GJ; Gilgamesh Pharmaceuticals, New York, NY, USA., Papp M; Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland., Sporn J; Gilgamesh Pharmaceuticals, New York, NY, USA., Hughes ZA; Gilgamesh Pharmaceuticals, New York, NY, USA.
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 May; Vol. 49 (6), pp. 905-914. Date of Electronic Publication: 2024 Jan 04.
Autor:
Wakabayashi Y; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Stenkrona P; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Arakawa R; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Yan X; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Van Buskirk MG; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Jenkins MD; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Santamaria JAM; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Maresca KP; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Takano A; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Liow JS; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Chappie TA; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Varrone A; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Nag S; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Zhang L; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Hughes ZA; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Schmidt CJ; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Doran SD; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Mannes A; Anesthesia Department, NIH Clinical Center, Bethesda, Maryland., Zanotti-Fregonara P; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Ooms M; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Morse CL; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Zoghbi SS; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Halldin C; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Pike VW; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Innis RB; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland; robert.innis@nih.gov.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Dec; Vol. 63 (12), pp. 1919-1924. Date of Electronic Publication: 2022 Jun 30.
Autor:
Scott L; Praxis Precision Medicines, Boston, Massachusetts, USA., Puryear CB; Praxis Precision Medicines, Boston, Massachusetts, USA., Belfort GM; Praxis Precision Medicines, Boston, Massachusetts, USA., Raines S; Praxis Precision Medicines, Boston, Massachusetts, USA., Hughes ZA; Praxis Precision Medicines, Boston, Massachusetts, USA., Matthews LG; Praxis Precision Medicines, Boston, Massachusetts, USA., Ravina B; Praxis Precision Medicines, Boston, Massachusetts, USA., Wittmann M; Praxis Precision Medicines, Boston, Massachusetts, USA.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2022 Jun; Vol. 37 (6), pp. 1193-1201. Date of Electronic Publication: 2022 Mar 07.
Autor:
Kahlig KM; Praxis Precision Medicines, Boston, Massachusetts, USA., Scott L; Praxis Precision Medicines, Boston, Massachusetts, USA., Hatch RJ; Praxis Precision Medicines, Boston, Massachusetts, USA.; Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia., Griffin A; Praxis Precision Medicines, Boston, Massachusetts, USA., Martinez Botella G; Praxis Precision Medicines, Boston, Massachusetts, USA., Hughes ZA; Praxis Precision Medicines, Boston, Massachusetts, USA., Wittmann M; Praxis Precision Medicines, Boston, Massachusetts, USA.
Publikováno v:
Epilepsia [Epilepsia] 2022 Mar; Vol. 63 (3), pp. 697-708. Date of Electronic Publication: 2022 Jan 17.
Autor:
Griffin AM; Praxis Precision Medicines, Research Innovation, Cambridge, Massachusetts 02142, United States., Kahlig KM; Praxis Precision Medicines, Research Innovation, Cambridge, Massachusetts 02142, United States., Hatch RJ; Praxis Precision Medicines, Research Innovation, Cambridge, Massachusetts 02142, United States.; The Florey Institute of Neuroscience and Mental Health, Melbourne, VIC 3052, Australia., Hughes ZA; Praxis Precision Medicines, Research Innovation, Cambridge, Massachusetts 02142, United States., Chapman ML; ICAGEN, Durham, North Carolina 27703, United States., Antonio B; ICAGEN, Durham, North Carolina 27703, United States., Marron BE; Praxis Precision Medicines, Research Innovation, Cambridge, Massachusetts 02142, United States., Wittmann M; Praxis Precision Medicines, Research Innovation, Cambridge, Massachusetts 02142, United States., Martinez-Botella G; Praxis Precision Medicines, Research Innovation, Cambridge, Massachusetts 02142, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2021 Mar 09; Vol. 12 (4), pp. 593-602. Date of Electronic Publication: 2021 Mar 09 (Print Publication: 2021).
Autor:
Graf R; Pfizer Internal Medicine Research Unit, Cambridge, MA, USA., Longo JL; Pfizer Internal Medicine Research Unit, Cambridge, MA, USA., Hughes ZA; Pfizer Internal Medicine Research Unit, Cambridge, MA, USA.
Publikováno v:
Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2018 Sep; Vol. 32 (9), pp. 1027-1036. Date of Electronic Publication: 2018 Jun 13.